FABP1 and Hepar expression levels in Barrett's Oesophagus and Associated Neoplasia in an Asian Population

Barrett's oesophagus (BE) is a premalignant condition associated with oesophageal adenocarcinoma (EAC). Evidence highlights that EAC is associated with an estimated 5-year survival of approximately 10-15%. Therefore, there is a need to determine which biomarkers are of value in the diagnosis of BE and beyond. The aim of our study was to evaluate the clinical significance of markers known to be expressed across BE and associated neoplasia.

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2vJYJSN
via IFTTT